[Seite 84↓]

Literatur

Aarts WM, Willemze R, Bende RJ, Meijer CJ, Pals ST, van Noesel CJ. VH gene analysis of primary cutaneous B-cell lymphomas: evidence for ongoing somatic hypermutation and isotype switching. Blood. 1998 Nov 15; 92(10): 3857-3864

Aboulafia DM. Primary cutaneous large B-cell lymphoma of the legs: a distinct clinical pathologic entity treated with CD20 monoclonal antibody (rituximab). Am J Clin Oncol. 2001 Jun; 24(3): 237-240

Ahnhudt C, Muche JM, Dijkstal K, Sterry W, Lukowsky A. An approach to the sensitivity of temperature-gradient gel electrophoresis in the detection of clonally expanded T-cells in cutaneous T-cell lymphoma. Electrophoresis. 2001 Jan; 22(1): 33-38

Akhtar S, Maghfoor I. Rituximab plus CHOP for diffuse large-B-cell lymphoma. N Engl J Med. 2002 Jun 6; 346(23): 1830-1831

Alibert JLM: Tableau du plan fonoide: Description des maladies de la peau, observée traitment. Barriois l’Aîné et Fils, Paris, 1806

Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Staudt LM, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000 Feb 3; 403(6769): 503-511

Allen D, Simon T, Sablitzky F, Rajewsky K, Cumano A. Antibody engineering for the analysis of affinity maturation of an anti-hapten response. EMBO J. 1988 Jul; 7(7): 1995-2001

Asadullah K, Docke WD, Volk HD, Sterry W. Cytokines and cutaneous T-cell lymphomas. Exp Dermatol. 1998 Dec; 7(6): 314-320

Asadullah K, Friedrich M, Docke WD, Jahn S, Volk HD, Sterry W. Enhanced expression of T-cell activation and natural killer cell antigens indicates systemic anti-tumor response in early primary cutaneous T-cell lymphoma. J Invest Dermatol. 1997 May; 108(5): 743-747

Asadullah K, Gellrich S, Haeussler-Quade A, Friedrich M, Docke WD, Jahn S, Sterry W. Cytokine expression in primary cutaneous germinal center cell lymphomas. Exp Dermatol. 2000 Feb; 9(1): 71-76

Auer IA, Gascoyne RD, Connors JM, Cotter FE, Greiner TC, Sanger WG, Horsman DE. t(11; 18)(q21; q21) is the most common translocation in MALT lymphomas. Ann Oncol. 1997 Oct; 8(10): 979-985

Bagot M, Martinvallet D, Echchakir H, Chabanette-Schirm F, Boumsell L, Bensussan A: Functional inhibitory receptors expressed by a cutaneous T cell lymphoma-specific cytolytic clonal T cell population. J Invest Dermatol 2000, 115: 994-999

Bagot M, Nikolova M, Schirm-Chabanette F, Wechsler J, Boumsell L, Bensussan A. Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas. Ann N Y Acad Sci. 2001 Sep; 941: 31-38

Bagot M, Wechsler J, Lescs MC, Revuz J, Farcet JP, Gaulard P. Intraepidermal localization of the clone in cutaneous T-cell lymphoma. J Am Acad Dermatol. 1992 Oct; 27(4): 589-593

Bahler DW, Campbell MJ, Hart S, Miller RA, Levy S, Levy R. Ig VH gene expression among human follicular lymphomas. Blood. 1991 Sep 15; 78(6): 1561-1568

Bahler DW, Levy R. Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc Natl Acad Sci U S A. 1992 Aug 1; 89(15): 6770-6774

Bahler DW, Swerdlow SH. Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjogren's syndrome) begin as nonmalignant antigen-selected expansions. Blood. 1998 Mar 15; 91(6): 1864-1872

Barbie V, Lefranc MP. The human immunoglobulin kappa variable (IGKV) genes and joining (IGKJ) segments. Exp Clin Immunogenet. 1998; 15: 171-183

Basarab T, Fraser-Andrews E-A, Orchard G, Whittaker S, Russel-Jones R. Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases. Br-J-Dermatol. 1998 139: 630-638

Bekkenk MW, Geelen FA, van Voorst Vader PC, Heule F, Geerts ML, van Vloten WA, Meijer CJ, Willemze R. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000, 95: 3653-3661

Bekkenk MW, Vermeer MH, Geerts ML, Noordijk EM, Heule F, van Voorst Vader PC, van Vloten WA, Meijer CJ, Willemze R. Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients. J Clin Oncol. 1999 Aug; 17(8): 2471-2478

Beljaards R-C, Kaudewitz P, Berti E et al. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients. Cancer. 1993; 71: 2097-2104

Berek C, Berger A, Apel M. Maturation of the immune response in germinal centers. Cell. 1991 Dec 20; 67(6): 1121-1129

Berek C, Milstein C. The dynamic nature of the antibody repertoire. Immunol Rev. 1988 Oct; 105: 5-26


[Seite innerhalb Literaturhinweis 85↓]

Beylot-Barry M, Groppi A, Vergier B, Pulford K, Merlio JP. Characterization of t(2; 5) reciprocal transcripts and genomic breakpoints in CD30+ cutaneous lymphoproliferations. Blood 1998, 91: 4668-4676

Beylot-Barry M, Vergier B, DeMascarel A, Beylot C, Merlio JP. p53 oncoprotein expression in cutaneous lymphoproliferations. Blood. 1997 Jul 1; 90(1): 354-371

Beylot-Barry M, Sibaud V, Thiebaut R, Vergier B, Beylot C, Delaunay M, Chene G, Dubus P, Merlio JP. Evidence that an identical T cell clone in skin and peripheral blood lymphocytes is an independent prognostic factor in primary cutaneous T cell lymphomas. J Invest Dermatol. 2001 Oct; 117(4): 920-926

Boehncke WH, Schulte-Rebbelmund H, Sterry W. Plasma cells in the dermal infiltrate of mycosis fungoides are of polyclonal origin. Acta Derm Venereol. 1989; 69(2): 166-9

Boni R, Xin H, Kamarashev J et al. Allelic deletion at 9p21-22 in primary cutaneous CD30(+) large cell lymphoma. J-Invest-Dermatol. 2000; 115: 1104-1107

Bonnekoh B, Schulz M, Franke I, Gollnick H. Complete remission of a primary cutaneous B-cell lymphoma of the lower leg by first-line monotherapy with the CD20-antibody rituximab. J Cancer Res Clin Oncol. 2002 Mar; 128(3): 161-166.

Borowitz MJ, Weidner A, Olsen EA, Picker LJ. Abnormalities of circulating T-cell subpopulations in patients with cutaneous T-cell lymphoma: cutaneous lymphocyte-associated antigen expression on T cells correlates with extent of disease. Leukemia. 1993 Jun; 7(6): 859-863

Braeuninger A, Kuppers R, Strickler JG, Wacker HH, Rajewsky K, Hansmann ML. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci U S A. 1997 Aug 19; 94(17): 9337-9342

Brauninger A, Kuppers R, Spieker T, Siebert R, Strickler JG, Schlegelberger B, Rajewsky K, Hansmann ML. Molecular analysis of single B cells from T-cell-rich B-cell lymphoma shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells. Blood. 1999 Apr 15; 93(8): 2679-2687.

Brezinschek HP, Brezinschek RI, Lipsky PE. Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol. 1995 Jul 1; 155(1): 190-202.

Brezinschek HP, J Immunol. 1995; Pascual V, Liu YJ, Magalski A, de Bouteiller O, Banchereau J, Capra JD. Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med. 1994 Jul 1; 180(1): 329-339

Bruggemann M, Muller HJ, Burger C, Rajewsky K. Idiotypic selection of an antibody mutant with changed hapten binding specificity, resulting from a point mutation in position 50 of the heavy chain. EMBO J. 1986 Jul; 5(7): 1561-1566.

Bryant E, Ronan SG, Iossifides IA. Plasma cell myeloma in a patient with a cutaneous T-cell lymphoma. Cancer. 1982 Nov 15; 50(10): 2122-2125

Burg G, Braun-Falco O. Morphological and functional differentiation and classification of cutaneous lymphomas. Bull Cancer. 1977; 64(2): 225-240.

Cerroni L, Kerl H. Primary cutaneous follicle center cell lymphoma. Leuk Lymphoma. 2001 Sep-Oct; 42(5): 891-900

Cerroni L, Signoretti S, Hofler G, Annessi G, Putz B, Lackinger E, Metze D, Giannetti A, Kerl H. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol. 1997 Nov; 21(11): 1307-1315

Cerroni L, Zochling N, Putz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol. 1997 Sep; 24(8): 457-461

Chang B, Casali P. The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today. 1994 Aug; 15(8): 367-373

Child FJ, Russell-Jones R, Woolford AJ, Calonje E, Whittaker SJ. Immunoglobulin heavy chain variable region family expression in primary cutaneous B-cell lymphomas. Br J Dermatol. 2001 Oct; 145(4): 680

Child FJ, Woolford AJ, Calonje E, Russell-Jones R, Whittaker SJ. Molecular analysis of the immunoglobulin heavy chain gene in the diagnosis of primary cutaneous B cell lymphoma. J Invest Dermatol. 2001 Oct; 117(4): 984-989.

Chott A, Vonderheid E-C, Olbricht S, Miao N-N, Balk S-P, Kadin M-E. The dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis. J-Invest-Dermatol. 1996; 106: 696-700

Christensen H-K, Thomsen K, Vejlsgaard G-L. Lymphomatoid papulosis: a follow-up study of 41 patients. Semin-Dermatol. 1994; 13: 197-201

Cook GP, Tomlinson IM, Walter G, Riethman H, Carter NP, Buluwela L, Winter G, Rabbitts TH. A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q. Nat Genet. 1994 Jun; 7(2): 162-168


[Seite innerhalb Literaturhinweis 86↓]

Cox JP, Tomlinson IM, Winter G. A directory of human germ-line V kappa segments reveals a strong bias in their usage. Eur J Immunol. 1994; 24: 827-836

Cumberbatch M, Gould SI, Peters SW, Kimber I. MHC class II expression by Langerhans cells and lymph node dentritic cells: possible evidence for maturation of Langerhans cells following contact sensetivity. J Immunol. 1991, 74: 414-419

Dalloul A, Laroche L, Bagot M, Mossalayi MD, Fourcade C, Thacker DJ, Hogge DE, Merle-Beral H, Debre P, Schmitt C. Interleukin-7 is a growth factor for Sezary lymphoma cells. J Clin Invest. 1992 Sep; 90(3): 1054-1060.

Davis T-H, Morton C-C, Miller-Cassman R, Balk S-P, Kadin M-E: Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N-Engl-J-Med. 1992; 326: 1115-1122

de Kan R, van 't Veer MB. Clinical features of CD30 (Ki-1) positive anaplastic large-cell lymphoma (ALCL). Review of the literature. Neth J Med. 1993 Dec; 43(5-6): 277-284. Review.

De Vita S, Boiocchi M, Ferraccioli G. B-cell lymphomagenesis and human autoimmune models. Adv Clin Path. 1997 Apr; 1(2): 103-114.

DeCoteau-JF; Butmarc-JR; Kinney-MC; Kadin-ME. The t(2; 5) chromosomal translocation is not a common feature of primary cutaneous CD30 lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin [see comments] Blood. 1996 Apr 15; 87(8): 3437-3441

Diamandidou E, Colome-Grimmer M, Fayad L, Duvic M, Kurzrock R. Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis. Blood. 1998 Aug 15; 92(4): 1150-1159

Dick HM, Mackie R. Distribution of HLA antigens in patients with mycosis fungoides. Dermatologica. 1977; 155(5): 275-282

Dorner T, Brezinschek HP, Brezinschek RI, Foster SJ, Domiati-Saad R, Lipsky PE. Analysis of the frequency and pattern of somatic mutations within nonproductively rearranged human variable heavy chain genes. J Immunol. 1997 Mar 15; 158(6): 2779-2789

Dorner T, Farner NL, Lipsky PE. Ig lambda and heavy chain gene usage in early untreated systemic lupus erythematosus suggests intensive B cell stimulation. J Immunol. 1999 Jul 15; 163(2): 1027-1036

Dorner T, Foster SJ, Brezinschek HP, Lipsky PE. Analysis of the targeting of the hypermutational machinery and the impact of

Du M, Diss TC, Xu C, Peng H, Isaacson PG, Pan L. Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia. 1996 Jul; 10(7): 1190-1197

Du MQ, Isaccson PG. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol. 2002 Feb; 3(2): 97-104. Review

Dummer R, Willers J, Kamarashev J, Urosevic M, Dobbeling U, Burg G. Pathogenesis of cutaneous lymphomas. Semin Cutan Med Surg. 2000 Jun; 19(2): 78-86

Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell. 1992 Feb 7; 68(3): 421-427

Duvic M. Bexarotene and DAB(389)IL-2 (denileukin diftitox, ONTAK) in treatment of cutaneous T-cell lymphomas: algorithms. Clin Lymphoma. 2000 Nov; 1 Suppl 1: 51-55

Edelson,-R-L: Photopheresis: a clinically relevant immunobiologic response modifier. Ann-N-Y-Acad-Sci. 1991 Dec 30; 636154-636164

Ehlich A, Kuppers R. Analysis of immunoglobulin gene rearrangements in single B cells. Curr Opin Immunol. 1995 Apr; 7(2): 281-284. Review

el-Azhary R-A, Gibson L-E, Kurtin P-J, Pittelkow M-R, Muller S-A. Lymphomatoid papulosis: a clinical and histopathologic review of 53 cases with leukocyte immunophenotyping, DNA flow cytometry, and T-cell receptor gene rearrangement studies. J-Am-Acad-Dermatol. 1994; 30: 210-218

Falini B, Pileri S, Pizzolo G, Durkop H, Flenghi L, Stirpe F, Martelli MF, Stein. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995, 85: 1-14

Falini B, Pileri S, Zinzani PL, Carbone A, Zagonel V, Wolf-Peeters C, Verhoef G, Menestrina F, Todeschini G, Paulli M, Lazzarino M, Giardini R, Aiello A, Foss HD, Araujo I, Fizzotti M, Pelicci PG, Flenghi L, Martelli MF, SantucciA. ALK+ lymphoma: clinico-pathological findings and outcome. Blood 1999, 93: 2697-2706

Feeney AJ, Lugo G, Escuro G. Human cord blood kappa repertoire. J Immunol. 1997; 158: 3761-3768

Fivenson DP, Hanson CA, Nickoloff BJ. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma. J Am Acad Dermatol. 1994 Nov; 31(5 Pt 1): 717-723

Foote J, Winter G. Antibody framework residues affecting the conformation of the hypervariable loops. J Mol Biol. 1992 Mar 20; 224(2): 487-499

Foster SJ, Brezinschek HP, Brezinschek RI, Lipsky PE. Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells. J Clin Invest. 1997 Apr 1; 99(7): 1614-1627


[Seite innerhalb Literaturhinweis 87↓]

Garatti SA, Roscetti E, Trecca D, Fracchiolla NS, Neri A, Berti E. bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas. Recent Results Cancer Res. 1995; 139: 249-261

Geelen FA, Vermeer MH, Meijer CJ, Van der Putte SC, Kerkhof E, Kluin PM, Willemze R. bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related. J Clin Oncol. 1998 Jun; 16(6): 2080-2085

Gellrich S, Golembowski S, Audring H, Jahn S, Sterry W. Molecular analysis of the immunoglobulin VH gene rearrangement in a primary cutaneous immunoblastic B-cell lymphoma by micromanipulation and single-cell PCR. J Invest Dermatol. 1997 Oct; 109(4): 541-545

Gellrich S, Lukowsky A, Schilling T, Rutz S, Muche JM, Jahn S, Audring H, Sterry W. Microanatomical compartments of clonal and reactive T cells in mycosis fungoides: molecular demonstration by single cell polymerase chain reaction of T cell receptor gene rearrangements. J Invest Dermatol. 2000 Oct; 115(4): 620-624

Gellrich S, Muche JM, Audring H, Sterry W. [Cutaneous B-cell lymphoma] Hautarzt. 2000 May; 51(5): 363-73; quiz 373-375

Gellrich S, Muche JM, Pelzer K, Audring H, Sterry W. [Anti-CD20 antibodies in primary cutaneous B-cell lymphoma. Initial results in dermatologic patients] Hautarzt. 2001 Mar; 52(3): 205-210

Gellrich S, Rutz S, Borkowski A, Golembowski S, Gromnica-Ihle E, Sterry W, Jahn S. Analysis of V(H)-D-J(H) gene transcripts in B cells infiltrating the salivary glands and lymph node tissues of patients with Sjogren's syndrome. Arthritis Rheum. 1999 Feb; 42(2): 240-247

Gellrich S, Rutz S, Golembowski S, Jacobs C, von Zimmermann M, Lorenz P, Audring H, Muche M, Sterry W, Jahn S. Primary cutaneous follicle center cell lymphomas and large B cell lymphomas of the leg descend from germinal center cells. A single cell polymerase chain reaction analysis. J Invest Dermatol. 2001 Dec; 117(6): 1512-1520

Gellrich S, S. Rutz, S. Lippert, P. Lorenz, S. Golembowski, H. Audring, W. Sterry, S. Jahn. Studying Ig Genes in Single B Lymphocytes by Micromanipulation and Single Cell PCR. Biochemica, Boehringer Mannheim, 11/ 97

Gellrich S. , J. Marcus Muche, Wolfram Sterry. Primär kutane Lymphome, Klinikarzt 2002, 31(5): 114-121

Gerard-Marchant R, Hamlin I, Lennert K, Rilke F, Stansfeld A, van Unnik J. Classification of non-Hodgkin lymphomas. Lancet 1974; 2: 406-408

Golembowski S, Gellrich S, Lorenz P, Rutz S, Audring H, Sterry W, Jahn S. Mainly unmutated V(H) genes rearranged in B cells forming germinal centers in a cutaneous pleomorphic T-cell lymphoma. J Cutan Pathol. 1999 Jan; 26(1): 6-12

Golembowski S, Gellrich S, von Zimmermann M, Rutz S, Lippert S, Audring H, Lorenz P, Sterry W, Jahn S. Clonal evolution in a primary cutaneous follicle center B cell lymphoma revealed by single cell analysis in sequential biopsies. Immunobiology. 2000 Apr; 201(5): 631-644

Gordon-BG; Weisenburger-DD; Warkentin-PI; Anderson-J; Sanger-WG; Bast-M; Gnarra-D; Vose-JM; Bierman-PJ; Armitage-JO; et-al. Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patients. Cancer. 1993 Jan 1; 71(1): 257-263

Grange F, Bagot M. [Prognosis of primary cutaneous lymphomas] Ann Dermatol Venereol. 2002 Jan; 129(1 Pt 1): 30-40

Gruss HJ, Duyster J, Herrmann F. Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease. Ann Oncol. 1996; 7: 19-26

Guigou V, Cuisinier AM, Tonnelle C, Moinier D, Fougereau M, Fumoux F. Human immunoglobulin VH and VK repertoire revealed by in situ hybridization. Mol Immunol. 1990 Sep; 27(9): 935-940

Hansen ER. Immunoregulatory events in the skin of patients with cutaneous T-cell lymphoma. Arch Dermatol. 1996 May; 132(5): 554-561

Hardy K, Wright C, Rice S, Tachataki M, Roberts R, Morgan D, Spanos S, Taylor D. Future developments in assisted reproduction in humans. Reproduction. 2002 Feb; 123(2): 171-183

Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994 Sep 1; 84(5): 1361-1392

Hawkins RE, Zhu D, Ovecka M, Winter G, Hamblin TJ, Long A, Stevenson FK. Idiotypic vaccination against human B-cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines. Blood. 1994 Jun 1; 83(11): 3279-3288

Heinzerling L, Dummer R, Kempf W, Schmid MH, Burg G. Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma. Arch Dermatol. 2000 Mar; 136(3): 374-378

Heinzerling LM, Urbanek M, Funk JO, Peker S, Bleck O, Neuber K, Burg G, von Den Driesch P, Dummer R. Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma. Cancer. 2000 Oct 15; 89(8): 1835-1844

Hentges F. B lymphocyte ontogeny and immunoglobulin production. Clin Exp Immunol. 1994 Jul; 97 Suppl 1: 3-9


[Seite innerhalb Literaturhinweis 88↓]

Herrmann JJ, Roenigk HH Jr, Hurria A, Kuzel TM, Samuelson E, Rademaker AW, Rosen ST. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up. J Am Acad Dermatol. 1995 Aug; 33(2 Pt 1): 234-242

Hillson JL, Karr NS, Oppliger IR, Mannik M, Sasso EH. The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A. J Exp Med. 1993 Jul 1; 178(1): 331-336

Hipp JD, Hipp JA, Lyday BW, Minev BR. Cancer vaccines: an update. In Vivo. 2000 Sep-Oct; 14(5): 571-85. Review

Hofbauer GF, Kessler B, Kempf W, Nestle FO, Burg G, Dummer R. Multilesional primary cutaneous diffuse large B-cell lymphoma responsive to antibiotic treatment. Dermatology. 2001; 203(2): 168-170

Holtl L, Rieser C, Papesh C, Ramoner R, Herold M, Klocker H, Radmayr C, Stenzl A, Bartsch G, Thurnher M. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J Urol. 1999 Mar; 161(3): 777-782

Hombach A, Muche JM, Gerken M, Gellrich S, Heuser C, Pohl C, Sterry W, Abken H. T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30(+) cutaneous lymphoma cells. Gene Ther. 2001 Jun; 8(11): 891-895

Hoppe RT, Medeiros LJ, Warnke RA, Wood GS. CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides. J Am Acad Dermatol. 1995 Mar; 32(3): 448-453

Hoppe,-R-T; Fuks,-Z; Bagshaw,-M-A. Radiation therapy in the management of cutaneous T-cell lymphomas. Cancer-Treat-Rep. 1979 Apr; 63(4): 625-632

Horie R, Watanabe T. CD30: expression and function in health and disease. Semin Immunol. 1998; 10: 457-470,

Hummel M, Tamaru J, Kalvelage B, Stein H. Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood. 1994 Jul 15; 84(2): 403-407

Hussell T, Isaacson PG, Crabtree JE, Dogan A, Spencer J. Immunoglobulin specificity of low grade B cell gastrointestinal lymphoma of mucosa-associated lymphoid tissue (MALT) type. Am J Pathol. 1993 Jan; 142(1): 285-292

Hussell T, Isaacson PG, Spencer J. Proliferation and differentiation of tumour cells from B-cell lymphoma of mucosa-associated lymphoid tissue in vitro. J Pathol. 1993 Feb; 169(2): 221-227

Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer. 1983 Oct 15; 52(8): 1410-1416

Isaacson PG. Gastrointestinal lymphomas of T- and B-cell types. Mod Pathol. 1999 Feb; 12(2): 151-158

Jacob J, Kelsoe G, Rajewsky K, Weiss U. Intraclonal generation of antibody mutants in germinal centres. Nature. 1991 Dec 5; 354(6352): 389-392.

Jaffe E-S, Harris N-L, Diebold J, Muller-Hermelink H-K. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. Am-J-Clin-Pathol. 1999 ; 111: 8-12

Jukes TH, King JL. Evolutionary nucleotide replacements in DNA. Nature. 1979 Oct 18; 281(5732): 605-606

Kabat EA, Wu TT. Attempts to locate complementarity-determining residues in the variable positions of light and heavy chains. Ann N Y Acad Sci. 1971 Dec 31; 190: 382-393

Kanavaros P, Ioannidou D, Tzardi M, Datseris G, Katsantonis J, Delidis G, Tosca A. Mycosis fungoides: expression of C-myc p62 p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus. Pathol Res Pract. 1994 Sep; 190(8): 767-774

Kempf W, Dummer R, Schmid MH, Fritz T, Wuthrich B, Burg G. Intralesional cisplatin for the treatment of cutaneous B-cell lymphoma. Arch Dermatol. 1998 Nov; 134(11): 1343-1345

Kersten B, Niemann B, Jahn S. Development of single-chain Fv fragments from a human anti-double-stranded DNA antibody to study the influence of somatic mutations on antigen binding. Exp Clin Immunogenet. 2001; 18(2): 96-99.

Klein U, Goossens T; Fischer M et al. Somatic hypermutation in normal and transformed human B cells. Immunol-Rev. 1998; 162: 261-280

Klein U, Kuppers R, Rajewsky K. Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood. 1997 Feb 15; 89(4): 1288-1298

Knaus PI, Lindemann D, DeCoteau JF, Perlman R, Yankelev H, Hille M, Kadin ME, Lodish HF. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol 1996, 16: 3480-3489

Knobler,-R. Extracorporeal photochemotherapy-present and future. Vox-Sang. 2000; 78 Suppl 2197-2201

Kocks C, Rajewsky K. Stable expression and somatic hypermutation of antibody V regions in B-cell developmental pathways. Annu Rev Immunol. 1989; 7: 537-559


[Seite innerhalb Literaturhinweis 89↓]

Koeppel MC, Stoppa AM, Resbeut M, Blaise D, Coignet M, Coulier L, Maraninchi D, Sayag J. Mycosis fungoides and allogenic bone marrow transplantation. Acta Derm Venereol. 1994 Jul; 74(4): 331-332

Kuppers R, Hansmann ML, Diehl V, Rajewsky K. Molecular single-cell analysis of Hodgkin and Reed-Sternberg cells. Mol Med Today. 1995 Apr; 1(1): 26-30

Küppers R, Hansmann ML, Rajewsky K: Micromanipulation and PCR analysis of single cell from tissue sections. In Weir DM, Blackwell C, Herzberg LA: Handbook of Experimental Immunology, 5th edn. Blackwell Scientific Publishers, Cambridge MA, 1995

Kuppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med. 1999 Nov 11; 341(20): 1520-1529

Kuppers R, Rajewsky K, Hansmann ML. Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression. Eur J Immunol. 1997 Jun; 27(6): 1398-1405

Kuppers R, Rajewsky K, Zhao M, Simons G, Laumann R, Fischer R, Hansmann ML. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 1994, 91: 10962-10966

Kuppers R, Zhao M, Hansmann ML, Rajewsky K. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J. 1993 Dec 15; 12(13): 4955-49567

Kuppers R. Hansmann ML, Rajewsky K. Micromanipulation and PCR analysis of single B-cells from tissue sections. In: Weir DM, Blackwell C, Herzberg LA (eds) Handbook of Experimental Immunology, Vol. 4. Oxford, Blackwell Science, 1997, pp 206.1-206.4

Kutting B, Bonsmann G, Metze D, Luger TA, Cerroni L. Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a. J Am Acad Dermatol. 1997 Feb; 36(2 Pt 2): 311-314

Kuzel TM, Roenigk HH Jr, Samuelson E, Herrmann JJ, Hurria A, Rademaker AW, Rosen ST. Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sezary syndrome. J Clin Oncol. 1995 Jan; 13(1): 257-263

Leenman-EE; Afanas'ev-BV; Pozharisskii-KM. [Role of Epstein-Barr virus in the pathogenesis of lymphogranulomatosis. Immunohistochemical and molecular-biological (hybridization in situ) research]. Arkh-Patol. 1999 Jan-Feb; 61(1): 15-22

Lefranc MP, Giudicelli V, Ginestoux C, Bodmer J, Muller W, Bontrop R, Lemaitre M, Malik A, Barbie V, Chaume D. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 1999; 27: 209-212

Lefranc MP. Unique database numbering system for immunogenetic analysis. Immunol Today. 1997; 18: 509

LeMaistre CF. DAB(389)IL-2 (denileukin diftitox, ONTAK): other potential applications. Clin Lymphoma. 2000 Nov; 1 Suppl 1: 37-40. Review.

Levi E, Wang Z, Petrogiannis-Haliotis T, Pfeifer WM, Kempf W, Drews R, Kadin ME: Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: a possible mechanism for disease progression. J Invest Dermatol 2000, 115: 1034-1040

Li G, Chooback L, Wolfe JT, Rook AH, Felix CA, Lessin SR, Salhany KE. Overexpression of p53 protein in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression. J Invest Dermatol. 1998 May; 110(5): 767-770

Li G, Salhany KE, Rook AH, Lessin SR: The pathogenesis of large cell transformation in cutaneous T-cell lymphoma is not associated with t(2; 5)(p23; q35) chromosomal translocation. J Cutan Pathol 1997, 24: 403-408

Lindhout E, Koopman G, Pals ST, de Groot C. Triple check for antigen specificity of B cells during germinal center reactions. Immunol Today. 1997 Dec; 18(12): 573-577

Linnemann T, Tumenjargal S, Gellrich S, Wiesmuller K, Kaltoft K, Sterry W, Walden P. Mimotopes for tumor-specific T lymphocytes in human cancer determined with combinatorial peptide libraries. Eur J Immunol. 2001 Jan; 31(1): 156-165

Linnemann T, Wiesmuller KH, Gellrich S, Kaltoft K, Sterry W, Walden P. A T-cell epitope determined with random peptide libraries and combinatorial peptide chemistry stimulates T cells specific for cutaneous T-cell lymphoma. Ann Oncol, 2000 11: 95-99

Lorincz AL. Cutaneous T-cell lymphoma (mycosis fungoides) Lancet. 1996 Mar 30; 347(9005): 871-876

Lu D, Duvic M Medeiros L-J, Luthra R, Dorfman D-M, Jones D. The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides. Am-J-Clin-Pathol. 2001 ; 115: 413-421

Lukowsky A, Audring H, Heiduk U, Muche M, Richter S, Sterry W. [Detection of monoclonal T-cells with TCR gamma PCR in mycosis fungoides] Hautarzt. 1998 Aug; 49(8): 641-645

[No authors listed] National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer. 1982 May 15; 49(10): 2112-2135


[Seite innerhalb Literaturhinweis 90↓]

Marks,-D-I; Rockman,-S-P; Oziemski,-M-A; Fox,-R-M. Mechanisms of lymphocytotoxicity induced by extracorporeal photochemotherapy for cutaneous T cell lymphoma. J-Clin-Invest. 1990 Dec; 86(6): 2080-2085

Matolcsy A, Schattner EJ, Knowles DM, Casali P. Clonal evolution of B cells in transformation from low- to high-grade ymphoma. Eur J Immunol. 1999 Apr; 29(4): 1253-1264

Matsuda F, Shin EK, Nagaoka H, Matsumura R, Haino M, Fukita Y, Taka-ishi S, Imai T, Riley JH, Anand R, et al. Structure and physical map of 64 variable segments in the 3'0. 8-megabase region of the human immunoglobulin heavy-chain locus. Nat Genet. 1993 Jan; 3(1): 88-94

McCurley TL, Collins RD, Ball E, Collins RD. Nodal and extranodal lymphoproliferative disorders in Sjogren's syndrome: a clinical and immunopathologic study. Hum Pathol. 1990 May; 21(5): 482-492

McGregor JM, Crook T, Fraser-Andrews EA, Rozycka M, Crossland S, Brooks L, Whittaker SJ. Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas. J Invest Dermatol. 1999 Mar; 112(3): 317-321

Meijer CJ, Jiwa NM, Dukers DF, Oudejans JJ, de Bruin PC, Walboomers JM, van den Brule AJ. Epstein-Barr virus and human T-cell lymphomas. Semin Cancer Biol. 1996 Aug; 7(4): 191-196

Molina A, Nademanee A, Arber DA, Forman SJ. Remission of refractory Sezary syndrome after bone marrow transplantation from a matched unrelated donor. Biol Blood Marrow Transplant. 1999; 5(6): 400-404.

Mori M, Manuelli C, Pimpinelli N, Mavilia C, Maggi E, Santucci M, Bianchi B. CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: A clue to the pathophysiology of clinical regression. Blood 1999, 94: 3077-3083

Mortari F, Wang JY, Schroeder HW Jr. Human cord blood antibody repertoire. Mixed population of VH gene segments and CDR3 distribution in the expressed C alpha and C gamma repertoires. J Immunol. 1993 Feb 15; 150(4): 1348-1357

Mozzanica N, Cattaneo A, Fracchiolla N, Boneschi V, Berti E, Gronda E, Mangiavacchi M, Finzi AF, Neri A. Posttransplantation cutaneous B-cell lymphoma with monoclonal Epstein-Barr virus infection, responding to acyclovir and reduction in immunosuppression. J Heart Lung Transplant. 1997 Sep; 16(9): 964-968

Muche JM, Gellrich S, Sterry W: Treatment of Cutaneous T-cell lymphomas. Seminars Cutan. Med. Surg. 2000, 19: 142-148

Muche JM, Lukowsky A, Asadullah K, Gellrich S, Sterry W. Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma. Blood. 1997 Aug 15; 90(4): 1636-1642

Muche JM, Lukowsky A, Heim J, Friedrich M, Audring H, Sterry W. Demonstration of frequent occurrence of clonal T cells in the peripheral blood but not in the skin of patients with small plaque parapsoriasis. Blood. 1999 Aug 15; 94(4): 1409-1417

Muschen M, Rajewsky K, Brauninger A, Baur AS, Oudejans JJ, Roers A, Hansmann ML, Kuppers R. Rare occurrence of classical Hodgkin's disease as a T cell lymphoma. J-Exp Med 2000, 191: 387-394

Nadali-G; Tavecchia-L; Zanolin-E; Bonfante-V; Viviani-S; Camerini-E; Musto-P; Di-Renzo-N; Carotenuto-M; Chilosi-M; Krampera-M; Pizzolo-G. Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome. Blood. 1998 Apr 15; 91(8): 3011-3016

Nagatani T, Miyazawa M, Matsuzaki T, Hayakawa H, Iemoto G, Kim ST, Baba N, Sugiyama A, Aihara M, Miyamoto H, et al. A case of cutaneous B-cell lymphoma treated successfully with MACOP-B. J Dermatol. 1993 Jan; 20(1): 40-44

Nickoloff BJ. Light-microscopic assessment of 100 patients with patch/plaque-stage mycosis fungoides. Am J Dermatopathol. 1988 Dec; 10(6): 469-477

Niedobitek-G: The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease. Ann-Oncol. 1996; 7 Suppl 4: 11-17

Oliven,-A; Shechter,-Y. Extracorporeal photopheresis: a review. Blood-Rev. 2001 Jun; 15(2): 103-108

Olsen,-E-A; Bunn,-P-A. Interferon in the treatment of cutaneous T-cell lymphoma. Hematol-Oncol-Clin-North-Am. 1995 Oct; 9(5): 1089-1107

Pascual V, Capra JD. VH4-21, a human VH gene segment overrepresented in the autoimmune repertoire. Arthritis Rheum. 1992 Jan; 35(1): 11-18

Pascual V, Cha S, Gershwin ME, Capra JD, Leung PS. Nucleotide sequence analysis of natural and combinatorial anti-PDC-E2 antibodies in patients with primary biliary cirrhosis. Recapitulating immune selection with molecular biology. J Immunol. 1994 Mar 1; 152(5): 2577-2585

Pascual V, Randen I, Thompson K, Sioud M, Forre O, Natvig J, Capra JD. The complete nucleotide sequences of the heavy chain variable regions of six monospecific rheumatoid factors derived from Epstein-Barr virus-transformed B cells isolated from the synovial tissue of patients with rheumatoid arthritis. Further evidence that some autoantibodies are unmutated copies of germ line genes. J Clin Invest. 1990 Oct; 86(4): 1320-1328

Pascual V, Verkruyse L, Casey ML, Capra JD. Analysis of Ig H chain gene segment utilization in human fetal liver. Revisiting the "proximal utilization hypothesis". J Immunol. 1993 Oct 15; 151(8): 4164-4172


[Seite innerhalb Literaturhinweis 91↓]

Pascual V, Victor K, Lelsz D, Spellerberg MB, Hamblin TJ, Thompson KM, Randen I, Natvig J, Capra JD, Stevenson FK. Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that the VH4-21 gene segment is responsible for the major cross-reactive idiotype. J Immunol. 1991 Jun 15; 146(12): 4385-4391.

Pasqualucci L, Migliazza A, Fracchiolla N, William C, Neri A, Baldini L, Chaganti RS, Klein U, Kuppers R, Rajewsky K, Dalla-Favera R. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci U S A. 1998 Sep 29; 95(20): 11816-11821

Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R, Dalla-Favera R. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 2001 Jul 19; 412(6844): 341-346

Paul T, Radny P, Krober SM, Paul A, Blaheta HJ, Garbe C. Intralesional rituximab for cutaneous B-cell lymphoma. Br J Dermatol. 2001 Jun; 144(6): 1239-1243

Paulli M, Berti E, Boveri E et al. Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily. Hum-Pathol. 1998; 29: 1223-1230

Paulli M, Berti E, Rosso R, Boveri E, Kindl S, Klersy C, Lazzarino M, Borroni G, Menestrina F, Santucci M, et al. CD30/Ki-1-positive lymphoproliferative disorders of the skin—clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J Clin Oncol. 1995 Jun; 13(6): 1343-1354

Peterfi T. Das mikrurgische Verfahren. Naturwissenschaften 1923, 11: 81

Portlock CS. CHOP and rituximab in elderly patients. Curr Oncol Rep. 2002 Sep; 4(5): 414

Potoczna N, Boehncke WH, Nestle FO, Kuenzlen C, Sterry W, Burg G, Dummer R. T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin. J Cutan Pathol. 1996 Aug; 23(4): 298-305

Preesman AH, Hu HZ, Tilanus MG, de Geus B, Schuurman HJ, Reitsma R, van Wichen DF, van Vloten WA, de Weger RA. T-cell receptor V beta-family usage in primary cutaneous and primary nodal T-cell non-Hodgkin's lymphomas. J Invest Dermatol. 1992 Nov; 99(5): 587-593

Pulford K, Morris SW, Mason DY. Anaplastic lymphoma kinase proteins and malignancy. Curr Opin Hematol. 2001 Jul; 8(4): 231-6. Review

Qin Y, Greiner A, Trunk MJ, Schmausser B, Ott MM, Muller-Hermelink HK. Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood. 1995 Nov 1; 86(9): 3528-3534

Rajewsky K, Kanzler H, Hansmann ML, Kuppers R. Normal and malignant B-cell development with special reference to Hodgkin's disease. Ann Oncol. 1997; 8 Suppl 2: 79-81. Review

Ralfkiaer E, Wollf-Sneedorff A, Vejlsgaard GL. Use of antibodies against the variable regions of the T-cell receptor alpha/beta heterodimer for the study of cutaneous T-cell lymphomas. Br J Dermatol. 1991 Nov; 125(5): 409-412

Rijlaarsdam JU, Toonstra J, Meijer OW, Noordijk EM, Willemze R. Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. J Clin Oncol. 1996 Feb; 14(2): 549-555

Rogers M. Pityriasis lichenoides and lymphomatoid papulosis. Semin Dermatol. 1992 Mar; 11(1): 73-79. Review.

Roggero E, Zucca E, Mainetti C, Bertoni F, Valsangiacomo C, Pedrinis E, Borisch B, Piffaretti JC, Cavalli F, Isaacson PG. Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol. 2000 Feb; 31(2): 263-268

Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Restifo NP, Sznol M, Schwarz SL, Spiess PJ, Wunderlich JR, Seipp CA, Einhorn JH, Rogers-Freezer L, White DE. Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine. J Immunol. 1999 Aug 1; 163(3): 1690-1695

Rosenquist R, Thunberg U, Li AH, Forestier E, Lonnerholm G, Lindh J, Sundstrom C, Sallstrom J, Holmberg D, Roos G. Clonal evolution as judged by immunoglobulin heavy chain gene rearrangements in relapsing precursor-B acute lymphoblastic leukemia. Eur J Haematol. 1999 Sep; 63(3): 171-179

Rudiger T, Ott G, Ott MM, Muller-Deubert SM, Muller-Hermelink HK. Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry. Am J Surg Pathol. 1998 Oct; 22(10): 1184-1191

Rudikoff S, Giusti AM, Cook WD, Scharff MD. Single amino acid substitution altering antigen-binding specificity. Proc Natl Acad Sci U S A. 1982 Mar; 79(6): 1979-1983

Sabroe RA, Child FJ, Woolford AJ, Spittle MF, Russell-Jones R. Rituximab in cutaneous B-cell lymphoma: a report of two cases. Br J Dermatol. 2000 Jul; 143(1): 157-161

Sakai A, Marti GE, Caporaso N, Pittaluga S, Touchman JW, Fend F, Raffeld M. Analysis of expressed immunoglobulin heavy chain genes in familial B-CLL. Blood. 2000 Feb 15; 95(4): 1413-1419


[Seite innerhalb Literaturhinweis 92↓]

Santana V, Rose NR. Neoplastic lymphoproliferation in autoimmune disease: an updated review. Clin Immunol Immunopathol. 1992 Jun; 63(3): 205-213

Scarisbrick JJ, Woolford AJ, Calonje E, Photiou A, Ferreira S, Orchard G, Russell-Jones R, Whittaker SJ. Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and sezary syndrome. J Invest Dermatol. 2002 Mar; 118(3): 493-499

Schiemann WP, Pfeifer WM, Levi E, Kadin ME, Lodish HF. A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma. Blood 1999, 15: 2854-2861

Schmoeckel C, Burg G, Braun-Falco O. Quantitative analysis of lymphoid cells in cutaneous low-grade malignant B-cell lymphomas. Arch Dermatol Res. 1979 Nov; 266(3): 239-251

Schutze K, Posl H, Lahr G. Laser micromanipulation systems as universal tools in cellular and molecular biology and in medicine. Cell Mol Biol (Noisy-le-grand). 1998 Jul; 44(5): 735-746

Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, Diehl V. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982, 299: 65-67

Seo,-N; Tokura,-Y; Matsumoto,-K; Furukawa,-F; Takigawa,-M. Tumour-specific cytotoxic T lymphocyte activity in Th2-type Sezary syndrome: its enhancement by interferon-gamma (IFN-gamma) and IL-12 and fluctuations in association with disease activity. Clin-Exp-Immunol. 1998 Jun; 112(3): 403-409

Shlomchik MJ, Aucoin AH, Pisetsky DS, Weigert MG. Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc Natl Acad Sci U S A. 1987 Dec; 84(24): 9150-9154.

Smoller BR, Bishop K, Glusac E, Kim YH, Hendrickson M. Reassessment of histologic parameters in the diagnosis of mycosis fungoides. Am J Surg Pathol. 1995 Dec; 19(12): 1423-1430.

Smoller BR, Longacre TA, Warnke RA. Ki-1 (CD30) expression in differentiation of lymphomatoid papulosis from arthropod bite reactions. Mod Pathol. 1992 Sep; 5(5): 492-496

Soda R, Costanzo A, Cantonetti M, Orlandi A, Bianchi L, Chimenti S. Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody. Acta Derm Venereol. 2001 Jun-Jul; 81(3): 207-208

Stachowitz S, Mempel M, Schmockel C, von Spanyi R, Abeck D. Variable course of patients with plaque parapsoriasis [correction of psoriasis]: lack of transformation into tumorous mycosis fungoides. Blood. 2000 Jun 1; 95(11): 3635-3636

Stadler,-R; Otte,-H-G; Luger,-T; Henz,-B-M; Kuhl,-P; Zwingers,-T; Sterry,-W. Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II. Blood. 1998 Nov 15; 92(10): 3578-3581

Starz H, Balda BR, Bachter D, Buchels H, Vogt H. Secondary lymph node involvement from primary cutaneous large B-cell lymphoma of the leg: sentinel lymph nodectomy as a new strategy for staging circumscribed cutaneous lymphomas. Cancer. 1999 Jan 1; 85(1): 199-207

Stein H, Hummel M, Marafioti T, Anagnostopoulos I, Foss HD. Molecular biology of Hodgkin's disease. Cancer Surv. 1997; 30: 107-123

Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985, 66: 848-858

Stein-H; Herbst-H; Anagnostopoulos-I; Niedobitek-G; Dallenbach-F; Kratzsch-HC. The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large-cell lymphoma. Ann-Oncol. 1991 Feb; 2 Suppl 2: 33-38

Steinhoff M, Hummel M, Anagnostopoulos I et al: Single Cell Analysis of CD30+ Cells in Lymphomatoid Papulosis demonstrates a Common Clonal T-Cell Origin. Blood First Edition Paper, prepublished online April 17, 2002; DOI 10. 1182/blood-2001-12-0199

Sterling JC, Marcus R, Burrows NP, Roberts SO. Erythrodermic mycosis fungoides treated with total body irradiation and

Stewart AK, Huang C, Long AA, Stollar BD, Schwartz RS. VH-gene representation in autoantibodies reflects the normal human B-cell repertoire. Immunol Rev. 1992 Aug; 128: 101-122

Streilein JW. Skin-associated lymphoid tissues (SALT): origins and functions. J Invest Dermatol. 1983; 80: 12-16

Talpur R, Apisarnthanarax N, Ward S, Duvic M. Treatment of refractory peripheral T-cell lymphoma with denileukin diftitox (ONTAK). Leuk Lymphoma. 2002 Jan; 43(1): 121-126

Tilgner J, Golembowski S, Kersten B, Sterry W, Jahn S. VH genes expressed in peripheral blood IgE-producing B cells from patients with atopic dermatitis. Clin Exp Immunol. 1997 Mar; 107(3): 528-535

Tilly H, Gaulard P, Lepage E, Dumontet C, Diebold J, Plantier I, Berger F, Symann M, Petrella T, Lederlin P, Briere J. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood 1997, 90: 3727-3734


[Seite innerhalb Literaturhinweis 93↓]

Tomlinson IM, Walter G, Jones PT, Dear PH, Sonnhammer EL, Winter G. The imprint of somatic hypermutation on the repertoire of human germline V genes. J Mol Biol. 1996 Mar 15; 256(5): 813-817

Tonegawa S. Somatic generation of antibody diversity. Nature. 1983 Apr 14; 302(5909): 575-581

Tonnies H, Stumm M, Wegner RD, Chudoba I, Kalscheuer V, Neitzel H. Comparative genomic hybridization based strategy for the analysis of different chromosome imbalances detected in conventional cytogenetic diagnostics. Cytogenet Cell Genet 2001, 93: 188-194

Trainor KJ, Brisco MJ, Wan JH, Neoh S, Grist S, Morley AA. Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction [see comments]. Blood 1991, 78: 192-196

Tzioufas AG, Katsikis PD, Youinou PY, Moutsopoulos HM. Sjogren's syndrome: an oligo-monoclonal B cell process. Clin Exp Rheumatol. 1990 Jul-Aug; 8 Suppl 5: 17-21

van der Putte SC, Toonstra J, van Wichen DF: B cells and plasma cells in mycosis fungoides. A study including cases with B cell follicle formation or a monotypical plasma cell component. Am J Dermatopathol. 1989 Dec; 11(6): 509-516

van Haselen CW, Vermeer MH, Toonstra J, van der Putte SC, Mulder PG, van Vloten WA, Willemze R. p53 and bcl-2 expression do not correlate with prognosis in primary cutaneous large T-cell lymphomas. J Cutan Pathol. 1997 Sep; 24(8): 462-467

Van Neer FJ, Toonstra J, Van Voorst Vader PC, Willemze R, Van Vloten WA. Lymphomatoid papulosis in children: a study of 10 children registered by the Dutch Cutaneous Lymphoma Working Group. Br J Dermatol. 2001 Feb; 144(2): 351-354

Vergier B, de Muret A, Beylot-Barry M, Vaillant L, Ekouevi D, Chene G, Carlotti A, Franck N, Dechelotte P, Souteyrand P, Courville P, Joly P, Delaunay M, Bagot M, Grange F, Fraitag S, Bosq J, Petrella T, Durlach A, De Mascarel A, Merlio JP, Wechsler J. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas. Blood. 2000 Apr 1; 95(7): 2212-2218

Vergier-B; Beylot-Barry-M; Pulford-K; Michel-P; Bosq-J; de-Muret-A; Beylot-C; Delaunay-MM; Avril-MF; Dalac-S; Bodemer-C; Joly-P; Groppi-A; de-Mascarel-A; Bagot-M; Mason-DY; Wechsler-J; Merlio-JP. Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases. Am-J-Surg-Pathol. 1998 Oct; 22(10): 1192-1202

Vermeer MH, Geelen FA, van Haselen CW, van Voorst Vader PC, Geerts ML, van Vloten WA, Willemze R. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group. Arch Dermatol. 1996 Nov; 132(11): 1304-1308

Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, de Vita S, et al. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993 Mar; 36(3): 340-347

Volkenandt M, Burmer GC, Schadendorf D, Koch OM, Wienecke R, Degitz K. The polymerase chain reaction. Method and applications in dermatopathology. Am J Dermatopathol 1993, 15: 118-126

Vonderheid EC. Treatment of cutaneous T cell lymphoma: 2001. Recent Results Cancer Res. 2002; 160: 309-320

Vonderheid EC; Tan ET; Kantor AF; Shrager L; Micaily B; Van-Scott EJ. Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma. J-Am-Acad-Dermatol. 1989 Mar; 20(3): 416-428

Wang H-H, Myers T, Lach L-J, Hsieh C-C, Kadin M-E. Increased risk of lymphoid and nonlymphoid malignancies in patients with lymphomatoid papulosis. Cancer. 1999 ; 86: 1240-1245

Watsky KL, Longley BJ, Dvoretzky I. Primary cutaneous B-cell lymphoma. Diagnosis, treatment, and prognosis. J Dermatol Surg Oncol. 1992 Nov; 18(11): 951-954

Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES, Raffeld M. Analysis of the t(2; 5)(p23; q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood. 1995 Sep 15; 86(6): 2321-2328

Whittaker S, Smith N, Jones R-R, Luzzatto L. Analysis of beta, gamma, and delta T-cell receptor genes in lymphomatoid papulosis: cellular basis of two distinct histologic subsets. J-Invest-Dermatol. 1991; 96: 786-791

Whittaker S. Clinical and prognostic significance of molecular studies in cutaneous T-cell lymphoma. Curr Top Pathol. 2001; 94: 93-101

Whittaker S. Molecular genetics of cutaneous lymphomas. Ann N Y Acad Sci. 2001 Sep; 941: 39-45

Whittemore AS, Holly EA, Lee IM, Abel EA, Adams RM, Nickoloff BJ, Bley L, Peters JM, Gibney C. Mycosis fungoides in relation to environmental exposures and immune response: a case-control study. J Natl Cancer Inst. 1989 Oct 18; 81(20): 1560-1567

WHO Clinical Advisory Committee meeting: Classification of neoplastic diseases of the hematopoietic and lymphoid systems: Airlie House, Virginia, USA, November, 1997


[Seite innerhalb Literaturhinweis 94↓]

Willemze R, Beljaards R-C. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J-Am-Acad-Dermatol. 1993 ; 28: 973-980

Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, vanVloten WA, Meijer CJ. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997, 90: 354-371

Willemze R, Meijer CJ. EORTC classification for primary cutaneous lymphomas: a comparison with the R. E. A. L. Classification and the proposed WHO Classification. Ann Oncol. 2000 11: 11-15

Williams SC, Frippiat JP, Tomlinson IM, Ignatovich O, Lefranc MP, Winter G. Sequence and evolution of the human germline V lambda repertoire. J Mol Biol. 1996 Nov 29; 264(2): 220-232

Winkler TH, Fehr H, Kalden JR. Analysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas. Eur J Immunol. 1992 Jul; 22(7): 1719-1728

Wood GS, Kamath NV, Guitart J, Heald P, Kohler S, Smoller BR, Cerroni L. Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States. J Cutan Pathol. 2001 Nov; 28(10): 502-507

Wood GS, Schaffer JM, Boni R, Dummer R, Burg G, Takeshita M, Kikuchi M. No evidence of HTLV-I proviral integration in lymphoproliferative disorders associated with cutaneous T-cell lymphoma. Am J Pathol. 1997 Feb; 150(2): 667-673

Wood GS. Lymphocyte activation in cutaneous T-cell lymphoma. J Invest Dermatol. 1995 Jul; 105(1 Suppl): 105-109

Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993 Sep 4; 342(8871): 575-577

Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991 Nov 9; 338(8776): 1175-1176

Wotherspoon AC, Pan LX, Diss TC, Isaacson PG. Cytogenetic study of B-cell lymphoma of mucosa-associated lymphoid tissue. Cancer Genet Cytogenet. 1992 Jan; 58(1): 35-38

Ye H, Dogan A, Karran L, Willis TG, Chen L, Wlodarska I, Dyer MJ, Isaacson PG, Du MQ. BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma. Am J Pathol. 2000 Oct; 157(4): 1147-1154

Zackheim HS; Epstein EH; Crain WR. Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15-year experience in 143 patients. J-Am-Acad-Dermatol. 1990 May; 22(5 Pt 1): 802-810

Zackheim HS; Kashani-Sabet M; Amin S. Topical corticosteroids for mycosis fungoides. Experience in 79 patients. Arch-Dermatol. 1998 Aug; 134(8): 949-954

Zenahlik P, Fink-Puches R, Kapp KS, Kerl H, Cerroni L. [Therapy of primary cutaneous B-cell lymphomas] Hautarzt. 2000 Jan; 51(1): 19-24

Zenone T, Catimel G, Barbet N, Clavel M. Complete remission of a primary cutaneous B cell lymphoma treated with intralesional recombinant interferon alpha-2a. Eur J Cancer. 1994; 30A(2): 246-247

Zinzani-PL; Pileri-S; Bendandi-M; Buzzi-M; Sabattini-E; Ascani-S; Gherlinzoni-F; Magagnoli-M; Albertini-P; Tura-S. Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients. J-Clin-Oncol. 1998 Apr; 16(4): 1532-1537

Zoi-Toli O, Vermeer MH, De Vries E, Van Beek P, Meijer CJ, Willemze R. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL. Br J Dermatol 2000, 143: 313-319


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
XDiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
02.06.2005